ORI OLD REPUBLIC INTERNATIONAL CORP Insider Trading

ORI director Risch Therace purchases 300 shares at open market; stock trades below recent highs amid modest pullback

Director Risch Therace bought a small position in Old Republic International as the stock sits noticeably below its recent highs following a near-term pullback. The timing is noteworthy because the director chose to deploy capital when the stock had already retreated, rather than at peak valuations. Old Republic is a solidly profitable company with strong revenue and earnings, trading at a reasonable valuation multiple that suggests the market isn't pricing in excessive growth expectations. The small size of this purchase—a 2.4% addition to holdings—indicates measured conviction rather than aggressive accumulation, consistent with a director using this dip as an entry point without signaling urgency. Whether this reflects genuine confidence in the stock's fundamentals or simply opportunistic buying at a temporary discount warrants watching for any follow-up activity from other insiders.

Director John Eric Smith bought 1,135 shares at $43.10 avg price (two transactions, $48,916.59), increasing holdings 36.1% to 4,276 shares.

Director John Eric Smith executed two separate open-market purchases totaling 1,135 shares for $48,916.59 on 2026-03-02, at a blended average price of $43.10, raising his holdings from 3,141 to 4,276 shares—a 36.1% increase in position size. The transaction occurred 8.9% below the 52-week high of $46.62 and just 1.5% above the current price of $42.46. Old Republic International trades at a P/E of 11.38 with recent quarterly net income of $279,500,000.00 against revenue of $2,424,300,000.00 and 11.0% annual revenue growth, suggesting a reasonably valued industrial/insurance business. The substantial expansion of a director's stake suggests conviction in the company's fundamentals, though without additional context on prior purchase frequency or scheduled trading plans, the motive remains an observable fact rather than an inference about confidence.

Director Risch Therace bought 1,000 shares (10.4% increase) at $39.14 avg; stock now $40.07, near 52-week highs.

Risch Therace purchased 1,000 shares across 2 separate transactions on 2025-11-03 at an average price of $39.14, expanding his holdings by 10.4% to 10,625 shares. The purchase occurred when the stock is trading at $40.07, within 7.9% of its 52-week high of $43.50, suggesting the director is buying near current market valuations rather than at depressed levels. ORI's fundamentals show solid operational performance with $2.4B in quarterly revenue, $279.5M net income, annual revenue growth of +13.4%, and a P/E ratio of 11.89, indicating the business is operationally healthy. His prior open-market purchase at this ticker (2024-04-30) delivered +14.0% by the 90-day mark, and his cross-ticker track record shows 100% 90-day win rate across 2 prior buys with +14.0% average return, establishing a pattern of well-timed acquisition decisions.

ORI Director Risch Therace buys 1,500 shares at $39.90; stock at 52-week high, +12.3% in 30 days

Risch Therace, a Director of Old Republic International, purchased 1,500 shares at $39.90 on September 2, 2025, increasing his holdings by 18.5% to 9,625 shares. The purchase occurred as ORI trades at $41.09, its 52-week high, after a +12.3% gain over the prior 30 days and +9.7% over 90 days. His prior purchase at this ticker on 2024-04-30 delivered +14.0% over 90 days, consistent with his broader cross-ticker track record showing a 100.00% 90-day win rate across 1 prior buy with +14.0% average return. The company trades at a 11.41 P/E with $2.2B in latest-quarter revenue and +13.4% annual revenue growth, suggesting a solid operational backdrop, though the timing of this buy coincides with the stock already at its 52-week high rather than at a depressed entry point.

Dare Thomas sold 27,457 shares for $1.0M at $36.50 average price, reducing stake from 74.0K to 46.6K shares (-37.1%).

DARE THOMAS, SrVP Secretary General Counsel at OLD REPUBLIC INTERNATIONAL CORP, executed 2 separate sales totaling 27,457 shares for $1,002,151.76 on 2025-03-11. The transaction reduced his holdings by 37.1%, from 74,013 shares to 46,556 shares post-transaction. The sales occurred at a blended average price of $36.50, near the current market price of $36.59 and well within the 52-week range of $28.64–$38.98. No FLAGS section provided indicates whether this was a scheduled 10b5-1 plan or discretionary open-market activity. The company fundamentals show solid operational performance with $2.3B quarterly revenue and 13.4% annual revenue growth, along with a conservative 7.62 P/E multiple.

Director Kovaleski buys 108 ORI shares at $37.46; stock down 8.6% from 52-week high. Modest purchase (+0.7% of holdings).

Director Charles J. Kovaleski purchased 108 shares of Old Republic International at $37.46 on 2024-12-16, increasing his holdings to 15,492 shares, a small net addition of 0.7% to his prior position. The purchase occurred near the upper range of ORI's 52-week trading band ($27.48–$38.98), with the stock currently trading at $35.63, down 8.6% from its 52-week high and down 5.4% over the prior 30 days. His prior trades at ORI show mixed timing: 4 of 5 prior purchases showed positive 90-day returns, though the magnitude varies (ranging from -0.2% to +16.4%), and this buy was placed at a near-peak price relative to recent trading ranges. The company trades at a P/E of 9.63 with $2.3B in quarterly revenue but faces an annual revenue decline of -10.2% year-over-year.

Director Kovaleski bought 114 shares of ORI at $35.43; 4 of 5 prior buys at this ticker well-timed with positive 90-day returns.

Director Charles J. Kovaleski purchased 114 shares of Old Republic International at $35.43, bringing his holdings to 15,384 shares (+0.7% increase). His prior transaction record at ORI is notably consistent: of 5 previous open-market purchases at this ticker, 4 exhibited positive 90-day returns (ranging from +0.7% to +16.4%), indicating a pattern of timely entry points. The current share price of $35.32 sits -1.6% below the 52-week high and reflects strong recent momentum (+14.8% over 90 days), providing context for the purchase decision. The company's valuation metrics (P/E 14.02, $9.1B market cap) appear reasonable relative to its revenue base, though the -10.2% annual revenue decline warrants monitoring of underlying business trends.

Director Kovaleski buys 267 ORI shares in 2 transactions (avg $29.86); prior 90d pattern: 3 of 4 buys well-timed.

KOVALESKI CHARLES J purchased 267 shares across two separate transactions dated 2024-03-21 and 2024-06-14 at a blended average price of $29.86, increasing his holdings from 15,002 to 15,269 shares (+1.8%). His prior trading history at ORI shows a consistent pattern of well-timed accumulation: 3 of 4 prior buys at this ticker generated positive 90-day returns, with a high success rate (buy on 2023-09-15: +6.4%, buy on 2023-06-15: +10.5%, buy on 2023-03-15: +4.0%). The current transaction occurred at prices near the 52-week range midpoint; the stock now trades at $30.27, -6.0% from its 52-week high. This purchase pattern aligns with the insider's documented selective accumulation strategy at ORI, though ORI itself shows elevated fundamentals risk with annual revenue declining -10.2% year-over-year despite a moderate P/E of 11.51.